BeOne Medicines Ltd. ONC
4 trading plans running, 45 Form 144 notices for $401.4M
10-Q, 10-K and Form 144What ONC's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From May 22, 2024 to Sep 8, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Xiaobin Wu President and Chief Operating Officer |
Ended 10b5-1 plan | Sep 15, 2026 | 10-Q Nov 5, 2026 | ||
| Dr. Xiaodong Wang Co-Founder and Director |
Adopted 10b5-1 plan | Jun 9, 2026 | 10-Q Aug 5, 2026 | ||
| Chan Lee Senior Vice President, General Counsel |
Adopted 10b5-1 plan | May 29, 2026 | 10-Q Aug 5, 2026 | ||
| John V. Oyler Co-Founder, Chief Executive Officer, and Chairman of the Board of Directors |
Adopted 10b5-1 plan | Mar 10, 2026 | 10-Q May 6, 2026 | ||
| Dr. Xiaobin Wu President, Chief Operating Officer |
Adopted 10b5-1 plan | Nov 7, 2025 | 10-K Feb 26, 2026 | ||
| Chan Lee Senior Vice President, General Counsel |
Adopted 10b5-1 plan | May 14, 2025 | 10-Q Aug 6, 2025 | ||
| Dr. Xiaobin Wu President, Chief Operating Officer |
Adopted 10b5-1 plan | May 14, 2025 | 10-Q Aug 6, 2025 | ||
| John V. Oyler Co-Founder, Chief Executive Officer, and Chairman of the Board of Directors |
Adopted 10b5-1 plan | Mar 12, 2025 | 10-Q May 7, 2025 | ||
| Julia Wang Former Chief Financial Officer |
Ended 10b5-1 plan | Sep 3, 2024 | 10-Q Nov 12, 2024 | ||
| Dr. Xiaodong Wang Co-Founder and Director |
Adopted 10b5-1 plan | Aug 12, 2024 | 10-Q Nov 12, 2024 | ||
| Dr. Lai Wang Global Head of R&D |
Adopted 10b5-1 plan | Jun 13, 2024 | 10-Q Aug 7, 2024 | ||
| Julia Wang Former Chief Financial Officer |
Adopted 10b5-1 plan | May 22, 2024 | 10-Q Aug 7, 2024 | ||
| Dr. Xiaobin Wu President, Chief Operating Officer |
Adopted 10b5-1 plan | May 13, 2024 | 10-Q Aug 7, 2024 | ||
| John V. Oyler Chief Executive Officer and Chairman |
Adopted 10b5-1 plan | Dec 12, 2023 | 10-K Feb 26, 2024 | ||
| Julia Wang Chief Financial Officer |
Adopted other arrangement | Dec 8, 2023 | 10-K Feb 26, 2024 | ||
| Lai Wang Global Head of R&D |
Adopted other arrangement | Dec 8, 2023 | 10-K Feb 26, 2024 | ||
| Chan Lee Senior Vice President, General Counsel |
Adopted other arrangement | Nov 28, 2023 | 10-K Feb 26, 2024 | ||
| Xiaobin Wu President, Chief Operating Officer and General Manager of China |
Adopted 10b5-1 plan | Nov 22, 2023 | 10-K Feb 26, 2024 | ||
| Chan Lee Senior Vice President |
Adopted plan | May 9, 2023 | 10-Q Aug 2, 2023 | ||
| Chan Lee Senior Vice President, General Counsel |
Adopted 10b5-1 plan | – | 10-Q May 8, 2024 | ||
What the company wroteName ( Title ) Action Taken ( Date of Action ) Type of Trading Arrangement Nature of Trading Arrangement Duration of Trading Arrangement Aggregate Number of Securities Chan Lee (Senior Vice President, General Counsel) Modification ( February 28, 2024 ) Rule 10b5-1 trading arrangement Sale May 30, 2025 1,440 ADSs plus an additional number of ADSs subject to RSUs equal to the net number of shares resulting from applicable RSU vestings after sell-to-cover for withholding tax. | |||||
Show the other 12 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 17 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 6, 2026 | TITUS BENJAMIN BALL Officer |
1,559 | $632K |
| Nov 5, 2026 | CHAN LEE Officer |
1,115 | $421K |
| Sep 30, 2026 | CHAN LEE Officer |
1,115 | $407K |
| Sep 8, 2026 | XIAODONG WANG Director, Chair, Scientific Advisory Brd |
131,370 | $47.1M |
| Sep 1, 2026 | TITUS BENJAMIN BALL Officer |
132 | $47K |
| Aug 25, 2026 | XIAOBIN WU Officer |
15,000 | $5.6M |
| Aug 25, 2026 | CORAZON D. SANDERS Former Director |
2,075 | $788K |
| Aug 11, 2026 | CHAN LEE Officer |
2,002 | $719K |
| Aug 10, 2026 | JOHN V OYLER Director, Officer |
240,810 | $83.9M |
| Aug 3, 2026 | AARON ROSENBERG Officer |
1,157 | $362K |
| Jul 30, 2026 | CHAN LEE Officer |
1,044 | $338K |
| Jul 22, 2026 | CHAN LEE Officer |
2,001 | $638K |
| Jul 14, 2026 | JOHN V OYLER Director, Officer |
513,574 | $156.1M |
| Jul 10, 2026 | JOHN V OYLER Director, Officer |
150,000 | $45.4M |
| Jul 10, 2026 | PAN-OYLER FOUNDATION Director, Officer |
49,541 | $15.0M |
| Jun 23, 2026 | LAI WANG Officer |
1,068 | $296K |
| Jun 23, 2026 | XIAOBIN WU Officer |
1,292 | $357K |
| Jun 23, 2026 | JOHN OYLER Officer, Director |
3,410 | $934K |
| Jun 16, 2026 | CHAN LEE Officer |
590 | $157K |
| Jun 16, 2026 | LAI WANG Officer |
1,169 | $310K |
| Jun 16, 2026 | XIAOBIN WU Officer |
1,357 | $362K |
| Jun 16, 2026 | JOHN OYLER Officer, Director |
3,693 | $981K |
| Jun 15, 2026 | CORAZON D. SANDERS Director |
945 | $251K |
| Jun 11, 2026 | XIAOBIN WU Officer |
626 | $164K |
| Jun 11, 2026 | LAI WANG Officer |
756 | $198K |
| Jun 11, 2026 | AARON ROSENBERG Officer |
631 | $163K |
| Jun 11, 2026 | TITUS BENJAMIN BALL Officer |
169 | $43K |
| Jun 11, 2026 | CHAN LEE Officer |
428 | $110K |
| Jun 11, 2026 | JOHN OYLER Officer, Director |
1,949 | $501K |
| Jun 8, 2026 | TITUS BENJAMIN BALL Officer |
136 | $37K |
| Jun 8, 2026 | CHAN LEE Officer |
871 | $236K |
| Jun 8, 2026 | LAI WANG Officer |
1,367 | $368K |
| Jun 8, 2026 | XIAOBIN WU Officer |
1,484 | $400K |
| Jun 8, 2026 | JOHN OYLER Officer, Director |
4,940 | $1.3M |
| Jun 1, 2026 | QINGQING YI Director |
235 | $66K |
| May 22, 2026 | MICHAEL GOLLER Director |
211 | $65K |
| May 22, 2026 | RANJEEV KRISHANA Director |
212 | $66K |
| May 22, 2026 | ALESSANDRO RIVA Director |
212 | $66K |
| May 22, 2026 | MARGARET DUGAN Director |
212 | $66K |
| May 22, 2026 | CORAZON D. SANDERS Director |
212 | $66K |
| May 13, 2026 | CHAN LEE Officer |
1,328 | $418K |
| Feb 4, 2026 | CHAN LEE Officer |
4,676 | $1.6M |
| Dec 15, 2025 | JOHN V OYLER Director, Officer |
100,000 | $31.9M |
| Nov 26, 2025 | CORAZON D. SANDERS Director |
2,627 | $896K |
| Nov 17, 2025 | XIAOBIN WU Officer |
3,991 | $1.5M |
Show the other 37 notices
From the Form 144 XML filed with the SEC, since Nov 17, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ONC/export.csv") into a cell.